Novotech Executive and Leadership Team

Vivek Kapoor, the Group Chief Financial Officer at Novotech, manages the financial health and fiscal strategy of the entire organization. Directing capital allocation and budgeting processes, the Group Chief Financial Officer ensures that resources support the company's mission of accelerating therapeutic development. Kapoor oversees financial reporting, risk management, and long-term investment planning to sustain growth across global operations. Vivek Kapoor also collaborates with the executive team to evaluate the financial viability of new service expansions and market entries. By maintaining robust financial controls, the Group Chief Financial Officer provides the stability necessary for the company to invest in advanced research technologies. This leadership role involves monitoring economic indicators to mitigate risks associated with international clinical trials. Through precise financial oversight, Kapoor supports the company's ability to deliver consistent value to biotech partners while ensuring the long-term sustainability of the business model in a highly competitive global research environment.

Michael Stibilj, the Chief Operating Officer at Novotech, directs all global clinical trial execution and operational workflows. Managing the complex logistics of multi-phase research, the Chief Operating Officer ensures that biotech partners receive high-quality data and efficient project delivery. Stibilj oversees the integration of regional teams across the Asia-Pacific and beyond, maintaining strict adherence to international clinical standards. By optimizing resource allocation and streamlining site management, the Chief Operating Officer drives significant improvements in trial timelines. Michael Stibilj also collaborates with the executive board to refine operational strategies that support the rapid advancement of novel therapeutics. Through rigorous oversight of clinical service delivery, Stibilj guarantees that every project meets the specific needs of the biotech industry. This leadership role focuses on scaling operational capacity to match the increasing demand for advanced medical research, ultimately securing the company's position as a premier global partner in clinical development.

Joseph Dumais, the President at Novotech, directs the overall corporate strategy and organizational growth. Overseeing the execution of the company's mission, the President ensures that all departments remain aligned with the goal of accelerating therapeutic development for biotech partners. Dumais manages the high-level relationships with key stakeholders and drives the expansion of service capabilities across global markets. Joseph Dumais also fosters a culture of innovation and operational excellence, empowering the leadership team to achieve ambitious performance targets. By setting the strategic vision, the President guides the company through the complexities of the CRO industry, ensuring that the organization remains at the forefront of clinical research. This role involves evaluating new business opportunities and overseeing the integration of advanced technologies into the research process. Through decisive leadership, Dumais secures the company's market position, ensuring that the organization continues to provide exceptional value to the global biotech community.

Melinda Borrelli, the Head of Medical Office Chief & Chief Marketing Officer, Operations at Novotech, architects the strategic alignment between medical expertise and market positioning. Overseeing the communication of clinical capabilities, the Head of Medical Office Chief & Chief Marketing Officer, Operations ensures that biotech clients understand the full scope of research services available. Borrelli drives brand awareness across global markets, highlighting the company's unique ability to accelerate therapeutic development. Melinda Borrelli also manages the medical office functions, ensuring that scientific integrity remains at the forefront of all marketing initiatives. By bridging the gap between complex clinical data and commercial outreach, the Head of Medical Office Chief & Chief Marketing Officer, Operations fosters strong partnerships with emerging biotech firms. This role involves analyzing market trends to tailor service offerings, thereby enhancing the company's competitive edge in the CRO landscape while maintaining a clear focus on delivering high-value research solutions.

Kristin Brown, the Chief Legal Officer at Novotech, governs all legal affairs, regulatory compliance, and contractual frameworks. Overseeing the complex legal requirements of global clinical research, the Chief Legal Officer ensures that every partnership adheres to international laws and ethical standards. Brown manages intellectual property protection and risk mitigation strategies, safeguarding the interests of both the company and its biotech clients. Kristin Brown also directs the legal team in navigating the regulatory landscapes of diverse geographic regions, facilitating smooth trial operations. By providing expert counsel on corporate governance and compliance, the Chief Legal Officer enables the organization to pursue innovative research projects with confidence. This role involves drafting and negotiating critical agreements that define the scope of clinical services. Through proactive legal management, Brown supports the company's commitment to integrity and excellence, ensuring that all research activities remain compliant with evolving global health regulations and industry best practices.

Judith Ng-Cashin, the Chief Medical Officer at Novotech, leads the scientific and medical strategy for all clinical research programs. Overseeing the design and execution of complex trials, the Chief Medical Officer ensures that therapeutic development meets the highest standards of safety and efficacy. Ng-Cashin provides expert guidance to biotech partners, helping to navigate the intricacies of drug development from early phases to regulatory approval. Judith Ng-Cashin also manages the medical team, fostering a culture of scientific excellence and innovation. By integrating clinical expertise into every project, the Chief Medical Officer drives the successful advancement of novel therapeutics. This leadership role involves collaborating with regulatory bodies to ensure that trial protocols align with global health requirements. Through deep medical insight and strategic oversight, Ng-Cashin enhances the company's ability to deliver high-quality research outcomes, ultimately accelerating the path for new treatments to reach patients in need across the global market.